vs

Side-by-side financial comparison of IF Bancorp, Inc. (IROQ) and Profound Medical Corp. (PROF). Click either name above to swap in a different company.

IF Bancorp, Inc. is the larger business by last-quarter revenue ($7.3M vs $6.0M, roughly 1.2× Profound Medical Corp.). IF Bancorp, Inc. runs the higher net margin — 18.1% vs -136.8%, a 154.9% gap on every dollar of revenue.

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

CompuGroup Medical SE & Co. KGaA is a German publicly listed software company based in Koblenz that develops and offers software for the healthcare sector. It produces cloud-based and digital application software to support medical and organizational activities in doctors' practices, pharmacies, medical laboratories and hospitals. According to its own figures, the company employed more than 9,200 people worldwide in 2022, and has over 1.6 million users in 56 countries. CompuGroup Medical shar...

IROQ vs PROF — Head-to-Head

Bigger by revenue
IROQ
IROQ
1.2× larger
IROQ
$7.3M
$6.0M
PROF
Higher net margin
IROQ
IROQ
154.9% more per $
IROQ
18.1%
-136.8%
PROF

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
IROQ
IROQ
PROF
PROF
Revenue
$7.3M
$6.0M
Net Profit
$1.3M
$-8.2M
Gross Margin
66.8%
Operating Margin
24.9%
-123.3%
Net Margin
18.1%
-136.8%
Revenue YoY
16.8%
Net Profit YoY
8.9%
EPS (diluted)
$0.41
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IROQ
IROQ
PROF
PROF
Q4 25
$7.3M
$6.0M
Q3 25
$7.3M
$5.1M
Q2 25
$6.9M
$2.0M
Q1 25
$6.4M
$2.3M
Q4 24
$6.3M
Q3 24
$6.2M
Q2 24
$5.7M
Q1 24
$5.4M
Net Profit
IROQ
IROQ
PROF
PROF
Q4 25
$1.3M
$-8.2M
Q3 25
$1.4M
$-8.0M
Q2 25
$1.4M
$-15.7M
Q1 25
$1.0M
$-10.7M
Q4 24
$1.2M
Q3 24
$633.0K
Q2 24
$431.0K
Q1 24
$708.0K
Gross Margin
IROQ
IROQ
PROF
PROF
Q4 25
66.8%
Q3 25
77.7%
Q2 25
81.7%
Q1 25
79.2%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
IROQ
IROQ
PROF
PROF
Q4 25
24.9%
-123.3%
Q3 25
26.0%
-176.2%
Q2 25
29.1%
-696.9%
Q1 25
21.7%
-477.0%
Q4 24
26.8%
Q3 24
13.7%
Q2 24
9.3%
Q1 24
17.6%
Net Margin
IROQ
IROQ
PROF
PROF
Q4 25
18.1%
-136.8%
Q3 25
19.0%
-157.7%
Q2 25
21.0%
-792.3%
Q1 25
15.8%
-458.1%
Q4 24
19.4%
Q3 24
10.2%
Q2 24
7.6%
Q1 24
13.1%
EPS (diluted)
IROQ
IROQ
PROF
PROF
Q4 25
$0.41
$0.27
Q3 25
$0.43
$0.26
Q2 25
$0.48
$0.52
Q1 25
$0.31
$0.36
Q4 24
$0.38
Q3 24
$0.20
Q2 24
$0.15
Q1 24
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IROQ
IROQ
PROF
PROF
Cash + ST InvestmentsLiquidity on hand
$8.8M
$59.7M
Total DebtLower is stronger
$4.5M
Stockholders' EquityBook value
$87.4M
$66.4M
Total Assets
$830.4M
$77.5M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IROQ
IROQ
PROF
PROF
Q4 25
$8.8M
$59.7M
Q3 25
$8.0M
$24.8M
Q2 25
$20.1M
$35.2M
Q1 25
$8.9M
$46.4M
Q4 24
$5.9M
Q3 24
$7.8M
Q2 24
$9.6M
Q1 24
$16.1M
Total Debt
IROQ
IROQ
PROF
PROF
Q4 25
$4.5M
Q3 25
$4.5M
Q2 25
$4.5M
Q1 25
$4.5M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IROQ
IROQ
PROF
PROF
Q4 25
$87.4M
$66.4M
Q3 25
$84.5M
$32.1M
Q2 25
$81.8M
$39.3M
Q1 25
$78.9M
$50.8M
Q4 24
$75.9M
Q3 24
$78.8M
Q2 24
$73.9M
Q1 24
$72.4M
Total Assets
IROQ
IROQ
PROF
PROF
Q4 25
$830.4M
$77.5M
Q3 25
$862.3M
$42.3M
Q2 25
$887.7M
$49.7M
Q1 25
$879.1M
$60.9M
Q4 24
$885.1M
Q3 24
$893.4M
Q2 24
$887.7M
Q1 24
$905.0M
Debt / Equity
IROQ
IROQ
PROF
PROF
Q4 25
0.07×
Q3 25
0.14×
Q2 25
0.11×
Q1 25
0.09×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IROQ
IROQ
PROF
PROF
Operating Cash FlowLast quarter
$1.8M
$-6.6M
Free Cash FlowOCF − Capex
$1.7M
FCF MarginFCF / Revenue
23.7%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters
$9.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IROQ
IROQ
PROF
PROF
Q4 25
$1.8M
$-6.6M
Q3 25
$-539.0K
$-9.6M
Q2 25
$6.8M
$-13.7M
Q1 25
$1.8M
$-8.3M
Q4 24
$-155.0K
Q3 24
$2.2M
Q2 24
$2.3M
Q1 24
$19.0K
Free Cash Flow
IROQ
IROQ
PROF
PROF
Q4 25
$1.7M
Q3 25
$-582.0K
Q2 25
$6.5M
Q1 25
$1.8M
Q4 24
$-226.0K
Q3 24
$2.1M
Q2 24
$2.0M
Q1 24
$-67.0K
FCF Margin
IROQ
IROQ
PROF
PROF
Q4 25
23.7%
Q3 25
-7.9%
Q2 25
95.1%
Q1 25
28.2%
Q4 24
-3.6%
Q3 24
33.6%
Q2 24
35.7%
Q1 24
-1.2%
Capex Intensity
IROQ
IROQ
PROF
PROF
Q4 25
0.9%
Q3 25
0.6%
Q2 25
3.5%
Q1 25
0.4%
Q4 24
1.1%
Q3 24
1.2%
Q2 24
4.3%
Q1 24
1.6%
Cash Conversion
IROQ
IROQ
PROF
PROF
Q4 25
1.36×
Q3 25
-0.39×
Q2 25
4.69×
Q1 25
1.81×
Q4 24
-0.13×
Q3 24
3.42×
Q2 24
5.30×
Q1 24
0.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons